Trypsin Inhibitor, Bowman-Birk Soybean
"Trypsin Inhibitor, Bowman-Birk Soybean" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low-molecular-weight protein (minimum molecular weight 8000) which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine.
Below are MeSH descriptors whose meaning is more general than "Trypsin Inhibitor, Bowman-Birk Soybean".
Below are MeSH descriptors whose meaning is more specific than "Trypsin Inhibitor, Bowman-Birk Soybean".
This graph shows the total number of publications written about "Trypsin Inhibitor, Bowman-Birk Soybean" by people in Harvard Catalyst Profiles by year, and whether "Trypsin Inhibitor, Bowman-Birk Soybean" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Trypsin Inhibitor, Bowman-Birk Soybean" by people in Profiles.
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prev Res (Phila). 2013 May; 6(5):410-8.
Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J Appl Physiol (1985). 2007 Mar; 102(3):956-64.
Other novel agents: Rationale and current status as chemopreventive agents. Urology. 2001 Apr; 57(4 Suppl 1):86-9.
Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells. Nutr Cancer. 1998; 31(1):8-17.
Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res. 1990 Feb 01; 50(3):580-6.